Literature DB >> 4760052

The relationship between plasma catecholamine concentration and pulse rate during exercise and standing.

N J Christensen, O Brandsborg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4760052     DOI: 10.1111/j.1365-2362.1973.tb00355.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


× No keyword cloud information.
  28 in total

1.  Decrease in plasma noradrenaline levels following long-term treatment with prindolol in patients with essential hypertension.

Authors:  H M Brecht; F Banthien; W Schoeppe
Journal:  Klin Wochenschr       Date:  1976-11-15

2.  Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro.

Authors:  A E Calogero; W T Gallucci; G P Chrousos; P W Gold
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

3.  Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise.

Authors:  B G Hansson; B Hökfelt
Journal:  Eur J Clin Pharmacol       Date:  1975-10-10       Impact factor: 2.953

4.  Long term treatment of moderate hypertension with penbutolol (Hoe 893d). II. Effect on the response of plasma catecholamines and plasma renin activity to insulin-induced hypoglycemia.

Authors:  B G Hansson
Journal:  Eur J Clin Pharmacol       Date:  1976-02-06       Impact factor: 2.953

5.  A sensitive radioenzymatic assay for adrenaline and noradrenaline in plasma.

Authors:  H Hörtnagl; C R Benedict; D G Grahame-Smith
Journal:  Br J Clin Pharmacol       Date:  1977-10       Impact factor: 4.335

6.  Effect of labetalol on plasma noradrenaline and adrenaline in hypertensive man.

Authors:  N J Christensen; J Trap-Jensen; T L Svendsen; S Rasmussen; P E Nielsen
Journal:  Eur J Clin Pharmacol       Date:  1978-12-01       Impact factor: 2.953

7.  Plasma renin activity and plasma catecholamines in intact and splenectomized running and swimming beagle dogs.

Authors:  J A Joles; J M den Hertog; G H Huisman; W J Kraan; F W van Schaik; A C Schrikker
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1982

8.  Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.

Authors:  D P Nicholls; J McNeill; P C O'Connor; D W Harron; W J Leahey; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

Review 9.  Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.

Authors:  B Holmes; E M Sorkin
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

10.  The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levels.

Authors:  E Agabiti-Rosei; C L Alicandri; M Beschi; M Castellano; R Fariello; E Montini; M L Muiesan; G Romanelli; G Muiesan
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.